It is considered as a universal cancer marker [4]–[8] with implications in ovarian cancer [9], colorectal adenocarcinoma [10], acute lymphocytic leukemia, acute myeloid leukemia, esophageal carcinoma, lung cancers, lymphoma, rhabdomyosarcoma [6], prostate carcinoma [11] etc. In addition to this, CYP1B1 plays an important role in embryonic eye development [12]–[14] and its mutations have been implicated in primary congenital glaucoma (PCG) [15]–[17]. This evidence concerns the gene CYP1B1 and primary congenital glaucoma.